Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Clinical trial NCT02893917 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02893917
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation Castration-Resistant Prostate Carcinoma Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation Metastatic Prostate Carcinoma Prostate Adenocarcinoma With Neuroendocrine Differentiation Stage IV Prostate Adenocarcinoma AJCC v7

Start date: 2017-08-11
Primary completion: 2023-03-14
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.